Developed in partnership with ASCP and MED-PASS, this new toolkit is a comprehensive look at the opioid crisis in America, and what pharmacists can do to positively impact patients and prescribers.

Two investigational SARS-CoV-2 neutralizing antibody treatments, bamlanivimab and casirivimab plus imdevimab are now available through Emergency Use Authorization (EUA) from the FDA for use in eligible outpatients with mild to moderate disease who are at high risk for disease progression and/or hospitalization.Residents of skilled nursing facilities (SNFs) are ideal for these novel therapies and long-term care (LTC) pharmacies provide intravenous medications (IV) routinely in SNF environments.

Released August 2020, this customizable, comprehensive set of standard operating procedures allows any compounding pharmacy to rapidly bring itself into compliance with PCAB/ACHC Accreditation Standards.

"The Nonsterile and Sterile Compounding Pharmacy Standard Operating Procedures is written to the proposed USP standards for <795>, <797> and <800>, with a heavy emphasis on quality control and assurance."

For the duration of the COVID-19 pandemic, ASCP recommends a close review of medications to help reduce the burden on pharmacists, residents, and nursing staff. To further limit entries to a patient room, consultants are encouraged to reduce routine medication monitoring and consolidate medication passes, whenever feasible. These decisions should be made in conjunction with the entire resident care team.

The American Society of Consultant Pharmacists conducts free webinars for all health care professionals and students to ensure consistent, up-to-date information regarding Coronavirus (COVID-19). Hear from the pharmacists and health professionals helping to care for some of the nursing facilities around the country already hit hard by the coronavirus and the next steps for the senior care community.

On December 1, 2019, USP General Chapter <800> - Hazardous Drugs – Handling in Healthcare Settings became official. Currently, <800> is informational and not compendially applicable.

This manual has been updated to include over 35 revised policies on medication compounding...